(2R,3S,4S,5R,6S)-4-(Allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran

Catalog No. :
ACGUWM730
CAS No. :
1017587-57-3
Molecular Formula :
C36H38O5S
Molecular Weight :
582.76

IUPAC Name:(2R,3S,4S,5R,6S)-4-(allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran

(2R,3S,4S,5R,6S)-4-(Allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$426.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,4S,5R,6S)-4-(Allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran
IUPAC Name(2R,3S,4S,5R,6S)-4-(allyloxy)-3,5-bis(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-2H-pyran
MDL No.MFCD11112183
Molecular FormulaC36H38O5S
Molecular Weight582.76
SMILESC=CCO[C@@H]([C@H]([C@@H](COCC1=CC=CC=C1)O2)OCC3=CC=CC=C3)[C@@H](OCC4=CC=CC=C4)[C@@H]2SC5=CC=CC=C5
InChI KeyOZARVANREPUDBF-BVMCXEQJSA-N
Synonym['Gal[246Bn,3All]-β-SPh']
CAS No.1017587-57-3
PubChem CID77620906

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGUWM730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUWM730 route product structure diagram
    ACGUWM7301017587-57-3
Inquiry

2. ACGUWM730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUWM730 route product structure diagram
    ACGUWM7301017587-57-3
Inquiry

Comments (0)